Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population

Clinical Infectious Diseases

Volumn 47, Issue 6, 2008, Pages 768-774

  Romney, Marc G ^a,b   Hull, Mark W ^a   Gustafson, Réka ^b,c   Sandhu, Jat ^c   Champagne, Sylvie ^a,b   Wong, Titus ^b   Nematallah, Anouf ^b   Forsting, Sara ^c   Daly, Patricia ^b,c  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Div of Tuberculosis Control   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; COCAINE; MOXIFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; DEMOGRAPHY; DRUG ABUSE; EMERGENCY CARE; EPIDEMIC; FEMALE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; POVERTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEROTYPING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; URBAN POPULATION; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRITISH COLUMBIA; CHILD; CHILD, PRESCHOOL; CRACK COCAINE; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; POVERTY AREAS; SEROTYPING; URBAN POPULATION; YOUNG ADULT;

EID: 51549102380     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/591128     Document Type: Article

References (42)

1. Gleich S, Morad Y, Echague R, et al. Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: report and review of recent outbreaks. Infect Control Hosp Epidemiol 2000; 21:711-7.
2. Nuorti JP, Butler JC, Crutcher JM, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998; 338:1861-8.
3. Cherian T, Steinhoff MC, Harrison LH, Rohn D, McDougal LK, Dick J. A cluster of invasive pneumococcal disease in young children in child care. JAMA 1994; 271:695-7.
4. Hoge CW, Reichler MR, Dominguez EA, et al. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med 1994; 331:643-8.
5. Crum NF, Wallace MR, Lamb CR, et al. Halting a pneumococcal pneumonia outbreak among United States Marine Corps trainees. Am J Prev Med 2003; 25:107-11.
6. Mercat A, Nguyen J, Dautzenberg B. An outbreak of pneumococcal pneumonia in two men's shelters. Chest 1991; 99:147-51.
7. Dagan R, Gradstein S, Belmaker I, et al. An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis 2000; 30:319-21.
8. Gratten M, Morey F, Dixon J, et al. An outbreak of serotype 1 Streptococcus pneumoniae infection in central Australia. Med J Aust 1993; 158:340-2.
9. City of Vancouver. 2005/6 Downtown eastside community monitoring report. 10th ed. 2007. Available at: http://www.city.vancouver.bc.ca/commsvcs/ planning/dtes/pdf/2006MR.pdf. Accessed 27 August 2007.
10. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997; 11:F59-65.
11. Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ 2006; 175:1399-404.
12. Davis TE, Fuller DD. Direct identification of bacterial isolates in blood cultures by using a DNA probe. J Clin Microbiol 1991; 29:2193-6.
13. Dawson S, Pallett A, Davidson A, Tuck A. Outbreak of multiresistant pneumococci. J Hosp Infect 1992; 22:328-9.
14. DeMaria A Jr, Browne K, Berk SL, Sherwood EJ, McCabe WR. An outbreak of type 1 pneumococcal pneumonia in a men's shelter. JAMA 1980; 244:1446-9.
15. Storm-weary Vancouver braces for major snowfall. Available at: http://www.cbc.ca/canada/story/2006/11/25/vancouver-weather.html Accessed 27 August 2007.
16. Talbot TR, Poehling KA, Hartert TV, et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med 2005; 118:285-91.
17. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 2005. 2006. Available at: http://www.cdc.gov/ncidod/dbmd/ abcs/survreports/spneu05.pdf. Accessed 27 August 2007.
18. Collins CL, Kerr T, Kuyper LM, et al. Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use. J Urban Health 2005; 82:276-84.
19. Dahl MS, Trollfors B, Claesson BA, Brandberg LL, Rosengren A. Invasive pneumococcal infections in southwestern Sweden: a second follow-up period of 15 years. Scand J Infect Dis 2001; 33:667-72.
20. Jackson ML, Neuzil KM, Thompson WW, et al. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis 2004; 39:1642-50.
21. Crack cocaine use among persons with tuberculosis - Contra Costa County, California, 1987-1990. MMWR Morb Mortal Wkly Rep 1991; 40:485-9.
22. Krause G, Blackmore C, Wiersma S, et al. Marijuana use and social networks in a community outbreak of meningococcal disease. South Med J 2001; 94:482-5.
23. Roth MD, Whittaker K, Salehi K, Tashkin DP, Baldwin GC. Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers. J Neuroimmunol 2004; 147:82-6.
24. Wolff AJ, O'Donnell AE. Pulmonary effects of illicit drug use. Clin Chest Med 2004; 25:203-16.
25. Friedman H, Pross S, Klein TW. Addictive drugs and their relationship with infectious diseases. FEMS Immunol Med Microbiol 2006; 47:330-42.
26. Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37:230-7.
27. Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis 2004; 4:21.
28. Alanee SR, McGee L, Jackson D, et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 2007; 45:46-51.
29. Konradsen HB, Kaltoft MS. Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol 2002; 9:358-65.
30. Jefferson T, Ferroni E, Curtale F, Giorgi Rossi P, Borgia P. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect Dis 2006; 6:405-10.
31. Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001; 285:1729-35.
32. Watt JP, O'Brien KL, Benin AL, et al. Invasive pneumococcal disease among Navajo adults, 1989-1998. Clin Infect Dis 2004; 38:496-501.
33. National Centre for Streptococcus, Provincial Laboratory for Public Health (Microbiology), Edmonton, Alberta, Canada, April 2004/March 2005 annual report. 2005. Available at: http://www2.provlab.ab.ca/ncs/NCS2004- 05_AnnualReport.pdf. Accessed 27 August 2007.
34. Bogaerts J, Lepage P, Taelman H, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from Rwanda, 1984-1990. J Infect 1993; 27:157-68.
35. John TJ, Pai R, Lalitha MK, et al. Prevalence of pneumococcal serotypes in invasive diseases in southern India. Indian J Med Res 1996; 104:205-7.
36. Tamayo M, Sa-Leao R, Santos Sanches I, Castaneda E, de Lencastre H. Dissemination of a chloramphenicol- and tetracycline-resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia. J Clin Microbiol 1999; 37:2337-42.
37. Kertesz DA, Di Fabio JL, de Cunto Brandileone MC, et al. Invasive Streptococcus pneumoniae infection in Latin American children: results of the Pan American Health Organization Surveillance Study. Clin Infect Dis 1998; 26:1355-61.
38. Porat N, Trefler R, Dagan R. Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel. J Clin Microbiol 2001; 39:1827-32.
39. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 2006; 25:602-7.
40. Kellner JD. Outbreaks of serotype 5 and serotype 8 invasive pneumococcal disease in Calgary, Alberta, Canada. ProMED-mail, 2006. Archive number 20061214.3520. Available at: http://www.promedmail.org. Accessed 14 April 2008.
41. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 2004; 190:1203-11.
42. National Advisory Committee on Immunization. Canadian immunization guide. 7th ed. Ottawa: Health Canada, 2006.